Omnicell's New Perioperative Clinic Setting Products May Boost Stock
The latest development expands the company's connected platform, intended to automate medication management processes and deliver intelligent insights to drive clinical and operational outcomes across all settings of care.
After the announcement yesterday, OMCL shares remained stable in the after-hours session. The ongoing staffing shortages in healthcare facilities and enterprise expansion lead to disconnected systems and processes, which often introduce opportunities for error and risk. By delivering scalable solutions that are designed to grow visibility, enhance intelligence and streamline workflows, Omnicell is helping close gaps in medication management across the care continuum. Accordingly, we expect the latest development to positively boost market sentiment toward OMCL stock.
Omnicell has a market capitalization of $1.31 billion at present. Going by the Zacks Consensus Estimate, the company's 2025 revenues are expected to improve 1.4%. In the last reported quarter, it delivered an earnings surprise of 62.5%.
The company believes that the path to the industry-defined vision of the Autonomous Pharmacy demands full visibility into medication use throughout the health system. The new MedTrack line of RFID products is designed to increase the accuracy and visibility of medications, streamline workflows and free time for clinicians to focus on higher-value work.
Image Source: Zacks Investment Research
The initial offering is MedTrack – OR, an RFID-enabled, single-deep drawer built to support operating room and anesthesia workflows and automatically track non-controlled medications without disrupting provider workflows. In the event of surgical emergencies, MedTrack OR is designed to provide instant access to essential medications while automatically updating Anesthesia WorkStation inventory counts once the user logs out.
Meanwhile, Omnicell's MedVision software helps a health system's outpatient clinics restock medications directly from central pharmacies or Centralized Services Centers (CSCs). The solution is intended to provide real-time clinic medication inventory data accessible through intuitive dashboards. It is engineered to trigger automatic reordering from the central pharmacy or CSC when established par levels get low.
The software also offers mobile device support for on-the-go inventory management in clinic storerooms and an optional integration with Epic medication administration record (MAR), which is built to automatically update inventory when a medication is administered from the electronic health record.
Per a Mordor Intelligence report, the global Hospital Asset Tracking and Inventory Management Systems market is expected to reach $31.05 billion in 2025 and expand at a compound annual growth rate (CAGR) of 5.5% through 2030. The market continues to witness significant transformation driven by technological advancements and the need for operational efficiency.
Concurrently, Omnicell announced the opening of its Austin, Texas Innovation Lab, which will serve as a hub focused on addressing challenges along the medication and supply journey. The facility will develop new technologies that are designed to solve evolving challenges faced by the healthcare industry.
Over the past three months,Omnicell shares have declined 27.4% compared with the industry's fall of 9.5%.
Omnicell currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader medical space are Hims & Hers Health HIMS, Inspira Medical Systems INSP and Cardinal Health CAH. Each of these carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Estimates for Hims & Hers Health's 2025 earnings per share have jumped 9.4% to 70 cents in the past 30 days. Shares of the company have surged 336.5% in the past year compared with the industry's 21% growth. HIMS' earnings surpassed estimates in two of the trailing four quarters, matched in one and missed on another occasion, the average surprise being 19.6%.
Inspira shares have dipped 2% in the past year. Estimates for the company's 2025 earnings per share have increased 2.6% to $2.26 in the past 30 days. INSP's earnings beat estimates in each of the trailing four quarters, the average surprise being 356.9%. In the last reported quarter, it posted an earnings surprise of 143.5%.
Estimates for Cardinal Health's fiscal 2025 earnings per share have increased 1.9% to $7.94 in the past 30 days. Shares of the company have jumped 50.4% in the past year against the industry's 3.5% fall. CAH's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 10.3%. In the last reported quarter, it delivered an earnings surprise of 9.3%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cardinal Health, Inc. (CAH) : Free Stock Analysis Report
Omnicell, Inc. (OMCL) : Free Stock Analysis Report
Inspire Medical Systems, Inc. (INSP) : Free Stock Analysis Report
Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
19 hours ago
- Business Insider
MountBay Energy Teams Up with Marquee Equity to Power AI growth
MountBay Energy LLC ('MountBay'), a next-generation clean-power developer focused on AI‑driven energy demands, announced today a strategic equity partnership with Marquee Equity, the specialist capital‑raise advisory firm. The alliance aims to accelerate MountBay's pipeline of utility‑scale solar, battery storage, and AI‑enabled grid management projects to support rapid expansion in data centers, healthcare, fintech, and other technology sectors. Marquee Equity brings deep fundraising expertise: with a track record of supporting over $3 billion in transaction value and 900+ fundraises, Marquee will guide MountBay through an investor roadmap strategy—from pitch deck refinement to LP outreach, access to Marquee's network of over 25,000 investment firms and 6,000 angels. Vrushabhraj Tanawade, CEO, MountBay Energy, commented: 'We're thrilled to partner with Marquee Equity. Their proven fundraising platform—from capital‑market structuring to investor engagement—will power our mission: delivering utility‑grade, AI‑optimized clean energy where it's most needed. This collaboration marks a critical milestone that positions MountBay as a leader at the nexus of infrastructure, technology, and sustainability.' MountBay is embracing a wave of major clean-energy investment trends: driven by private-equity firms and global clean‑energy investors looking to deploy capital into renewable tech, storage, and grid‑resilience projects. Deals like ReNew Energy's $100 million marquee investment from British International Investment highlight the appetite for capital-intensive, scalable clean-power infrastructure. Nikita Garg, Director at Marquee Equity, added: 'MountBay represents exactly the kind of forward-thinking, impact-driven partner we look to back—blending AI, infrastructure, and clean energy to solve some of the decade's most urgent power demands. We're excited to bring our investor network and capital strategy to the table to help scale this vision globally.' Key strategic objectives powered by the partnership: Capital raise of $980 million – 1.1 billion to expedite deployment of large-scale solar + BESS projects. Rapid turnkey delivery of AI-enabled microgrids to hyperscalers and edge-data facilities. De-risked development path via investor-led governance, improved capital structure, and enhanced market positioning ahead of future rounds. 'Why now?' MountBay sits at a pivotal crossroads: while hyperscalers require dependable, low-carbon power, traditional tax-equity sponsors are squeezed by rising interest rates—creating demand for alternative funding structures. With Marquee's capital-raise muscle and MountBay's technical proficiency in AI-powered grid and renewable assets, the partnership is uniquely positioned to deliver scale, ROI, and ESG impact. Investors interested in learning more about the round, project pipeline, or participating in future financings are invited to contact: Investor Relations MountBay Energy LLC vrushabhraj@ About MountBay Energy MountBay is redefining clean energy for the AI era. Specializing in large-scale solar, battery storage, grid-interactive solutions, and predictive AI-based energy management, MountBay's mission is to build resilient, clean, and cost‑effective power for next-gen infrastructure. About Marquee Equity Marquee Equity is a leading capital-raise advisor, supporting businesses across technology, infrastructure, and energy sectors. With over $3 billion in transaction history, Marquee offers full-service fundraising—from deck creation to investor strategy and outreach.
Yahoo
2 days ago
- Yahoo
Bulgaria Equips National Police Service with over 13,000 Motorola Solutions Body Cameras
Nationwide deployment will enhance awareness, safety and operational efficiency CHICAGO, July 31, 2025--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI) today announced that it has been selected by the Ministry of the Interior in Bulgaria to deploy 13,400 body cameras to the country's National Police Service. The nationwide rollout will help to foster transparency in law enforcement operations, deliver real-time field intelligence to police control rooms and enhance the safety of both the public and officers in Bulgaria. The deployment of V500 body cameras addresses community expectations for greater transparency and efficiency in police operations and will help accelerate and improve the force's response to everyday incidents and emergencies. "These new body cameras are a pivotal element in our digitalization strategy to modernize policing and elevate how we safeguard and serve our communities," said Daniel Mitov, Minister of the Interior in Bulgaria. "This investment underscores our commitment to promoting trust and transparency in our law enforcement operations while enhancing the real-time visibility and collaboration between our officers in the field and our control room personnel. We're proud of these significant steps forward in creating a safer Bulgaria for everyone to enjoy." "Front-line teams often operate in high-stress environments where their focus must remain entirely on the situation at hand," said Axel Kukuk, vice president, Sales Europe, Motorola Solutions. "Body cameras enable eyes-on-scene for greater clarity as events unfold, while helping to create a reliable and accurate record of critical events. Bulgaria's nationwide deployment is yet another exemplary model for how this technology can drive safer and more secure outcomes for all." The National Police Service will deploy the cameras alongside Motorola Solutions' VideoManager evidence management software, empowering officers to effortlessly upload, securely store and efficiently manage video footage as part of the agency's existing daily workflows. The LTE-enabled V500 body cameras also seamlessly integrate with Motorola Solutions' MXP600 TETRA radios, which Bulgarian police officers already rely on for voice communication. With a press of the emergency button on their radios, officers can call for assistance while simultaneously streaming live footage from their body cameras to the control room, providing multiple streams of information and greater situational awareness to command staff. Bulgaria's National Police Service joins a growing network of public safety organizations across Europe that rely on Motorola Solutions' body camera solutions. These include the French National Police and Gendarmerie, the Lithuanian Border Guard Service, German federal state police forces, and many other public safety organisations across the U.K., Belgium and Romania. About Motorola Solutions | Solving for safer Safety and security are at the heart of everything we do at Motorola Solutions. We build and connect technologies to help protect people, property and places. Our technologies support public safety agencies and enterprises alike, enabling the collaboration that's critical for safer communities, safer schools, safer hospitals and safer businesses. Learn more about our commitment to innovating for a safer future for us all at View source version on Contacts Media Contact Susanne StierMotorola SolutionsMobile: +49 172 616 1773Email:
Axios
2 days ago
- Axios
Workers are spilling secrets to chabots
Sensitive corporate data appeared in more than 4% of generative AI prompts and over 20% of uploaded files in the second quarter of this year, according to new research from Harmonic Security, released Thursday. The big picture: The problem isn't new, but as workplace genAI use increases, many employers still lack or don't enforce AI policies, causing employees to use bots in secret or without proper training. By the numbers: Harmonic Security sampled a million prompts and 20,000 files submitted to 300 genAI tools and AI-enabled SaaS applications between April and June. 43,700 of the prompts (4.4%) and 4,400 of the uploaded files (22%) contained sensitive information. Between the lines: Personal and free chatbot accounts make up a large share of corporate data exposure. Nearly half (47.42%) of sensitive uploads to Perplexity were from users with standard (non-enterprise) accounts. About a quarter of the prompts with sensitive information came through the free version of ChatGPT, and another 15% of sensitive prompts were submitted via free versions of Google Gemini accounts. Zoom in: Overall, including free and paid tiers, ChatGPT was by far the biggest source of prompt-based information exposure, followed by Microsoft Copilot and Google Gemini. Code was the most common type of sensitive data sent to chatbots. Harmonic says code was "especially prevalant in ChatGPT, Claude, DeepSeek and Baidu Chat." The number of prompts containing proprietary code was disproportionately high in Claude, which is often regarded as the best AI tool for coders. Sensitive prompts to ChatGPT involved M&A planning, financial modeling, and investor communications. The intrigue: Tools that feel safe — like document editors or design platforms — may now include genAI features trained on user data, creating exposure risk that bypasses traditional controls, Harmonic says. Harmonic found that Canva, Replit, Grammarly, and other tools with LLMs embedded inside them were used for legal strategy, internal emails, client data, and code. These uses were often not flagged as AI tools by corporate systems.
